Natural Killing of Herpes Simplex Virus Type 1-infected Target Cells: Normal Human Responses and Influence of Antiviral Antibody

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1979 Oct 1

PMID 227799

Citations 46

Authors

C Ching

C Lopez

Affiliations

Soon will be listed here.

Abstract

Studies of a mouse model of genetic resistance to herpes simplex virus type 1 (HSV-1) indicate that the marrow-dependent effector cell of allogeneic resistance plays an important role in natural resistance to this virus infection. Since the marrow-dependent effector cell appears to be closely related to the natural killer (NK) cells, an NK assay with HSV-1-infected fibroblasts [NK(HSV-1)] has been developed to study this resistance mechanism in humans. Incubation of effector and target cells for 12 to 14 h gave the greatest percent specific release (%SR) and kept spontaneous (51)Cr release from infected target cells below 35%. Patients with Bruton's agammaglobulinemia demonstrated significant kill indicating antiviral antibody was not necessary. Seropositive individuals gave a 9% greater%SR than seronegative individuals. Depletion of B-cells consistently diminished NK (HSV-1) for seropositive individuals and augmented kill for seronegative individuals. Although antiviral antibody produced in culture may contribute to NK (HSV-1), depletion of B-cells allowed quantitation of NK (HSV-1) to the exclusion of most of the antibody-dependent kill. The NK cells detected by this assay showed many of the properties reported for NK cells with K562 targets. Two patients with severe herpesvirus infections demonstrated NK (HSV-1) responses greater than 2 standard deviations below the normal mean. Since normal individuals with virus infections have higher rather than lower natural kill, the low NK (HSV-1) may reflect their susceptibility to the virus infection.

Citing Articles

CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.

Davis Z, Sowrirajan B, Cogswell A, Ward J, Planelles V, Barker E AIDS Res Hum Retroviruses. 2016; 33(2):93-100.

PMID: 27296670 PMC: 5312608. DOI: 10.1089/AID.2015.0375.

Innate and adaptive immune responses to herpes simplex virus.

Chew T, Taylor K, Mossman K Viruses. 2011; 1(3):979-1002.

PMID: 21994578 PMC: 3185534. DOI: 10.3390/v1030979.

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.

Bjorkstrom N, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M J Exp Med. 2010; 208(1):13-21.

PMID: 21173105 PMC: 3023129. DOI: 10.1084/jem.20100762.

Implications for gene therapy-limiting expression of IL-2R gamma c delineate differences in signaling thresholds required for lymphocyte development and maintenance.

Orr S, Roessler S, Quigley L, Chan T, Ford J, OConnor G J Immunol. 2010; 185(3):1393-403.

PMID: 20592278 PMC: 6417809. DOI: 10.4049/jimmunol.0903528.

Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.

Long B, Erickson A, Chapman J, Barbour J, Vu B, Ho E Immunology. 2009; 129(2):186-96.

PMID: 19824915 PMC: 2814461. DOI: 10.1111/j.1365-2567.2009.03170.x.

References

Russell A, Essery G . Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease. Cancer. 1977; 40(1):42-5. DOI: 10.1002/1097-0142(197707)40:1<42::aid-cncr2820400109>3.0.co;2-f. View

Santoli D, Trinchieri G, KOPROWSKI H . Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J Immunol. 1978; 121(2):532-8. View

Shore S, Milgrom H, Wood P, Nahmias A . Antibody-dependent cellular cytotoxicity to target cells infected with herpes simplex viruses: functional adequacy in the neonate. Pediatrics. 1977; 59(1):22-8. View

Moller-Larsen A, Heron I, Haahr S . Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun. 1977; 16(1):43-7. PMC: 421485. DOI: 10.1128/iai.16.1.43-47.1977. View

Lopez C, OReilly R . Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay. J Immunol. 1977; 118(3):895-902. View

Neiman P, Thomas E, REEVES W, RAY C, Sale G, Lerner K . Opportunistic infection and interstitial pneumonia following marrow transplantation for aplastic anemia and hematologic malignancy. Transplant Proc. 1976; 8(4):663-7. View

Berlinger N, Lopez C, Lipkin M, VOGEL J, GOOD R . Defective recognitive immunity in family aggregates of colon carcinoma. J Clin Invest. 1977; 59(5):761-9. PMC: 372283. DOI: 10.1172/JCI108697. View

Lopez C . Immunological nature of genetic resistance of mice to herpes simplex virus type 1 infection. IARC Sci Publ (1971). 1978; (24 Pt 2):775-81. View

Welsh Jr R . Mouse natural killer cells: induction specificity, and function. J Immunol. 1978; 121(5):1631-5. View

10.

Herberman R, HOLDEN H . Natural cell-mediated immunity. Adv Cancer Res. 1978; 27:305-77. DOI: 10.1016/s0065-230x(08)60936-7. View

11.

Haller O, Wigzell H . Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J Immunol. 1977; 118(4):1503-6. View

12.

Haller O, Hansson M, Kiessling R, Wigzell H . Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature. 1977; 270(5638):609-11. DOI: 10.1038/270609a0. View

13.

Clark E, Harmon R, Wicker L . Resistance of H-2 heterozygous mice to parental tumors. II. Characterization of Hh-1 controlled hybrid resistance to syngeneic fibrosarcomas and the EL-4 lymphoma. J Immunol. 1977; 119(2):648-56. View

14.

Kiessling R, Klein E, Wigzell H . "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975; 5(2):112-7. DOI: 10.1002/eji.1830050208. View

15.

Nahmias A, Roizman B . Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med. 1973; 289(13):667-74. DOI: 10.1056/NEJM197309272891305. View

16.

Armstrong D, Young L, Meyer R, Blevins A . Infectious complications of neoplastic disease. Med Clin North Am. 1971; 55(3):729-45. DOI: 10.1016/s0025-7125(16)32514-7. View

17.

Jondal M, Holm G, Wigzell H . Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972; 136(2):207-15. PMC: 2139198. DOI: 10.1084/jem.136.2.207. View

18.

CUDKOWICZ G, Bennett M . Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med. 1971; 134(1):83-102. PMC: 2139037. DOI: 10.1084/jem.134.1.83. View

19.

Rager-Zisman B, Bloom B . Immunological destruction of herpes simplex virus I infected cells. Nature. 1974; 251(5475):542-3. DOI: 10.1038/251542a0. View

20.

Shore S, Nahmias A, Starr S, Wood P, McFarlin D . Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature. 1974; 251(5473):350-2. DOI: 10.1038/251350a0. View